Journal of Literature Pharmacy Sciences

Postbiyotikler ve Sağlık Üzerine Etkileri: Sistematik Derleme
Postbiotics and Their Effects on Health: Systematic Review
Yasemin AÇARa, Pınar SÖKÜLMEZ KAYAa
aOndokuz Mayıs Üniversitesi Sağlık Bilimleri Fakültesi, Beslenme ve Diyetetik Bölümü, Samsun, TÜRKİYE
J Lit Pharm Sci. 2021;10(2):276-84
doi: 10.5336/pharmsci.2021-82004
Article Language: TR
Full Text
ÖZET
 İntestinal mikrobiyota sindirim sistemi, deri, ürogenital sistem ve solunum sisteminde bulunan çeşitli mikroorganizmalardan oluşmaktadır. Probiyotik, prebiyotik ve bu 2 bileşenin kombinasyonundan oluşan sinbiyotikler mikrobiyota homeostazınının sağlanmasında önemli bir rol oynamaktadır. Postbiyotik kavramı ise probiyotik, prebiyotik ve sinbiyotiklere kıyasla son yıllarda gelişmekte olan yeni bir kavramdır. Probiyotik, bakterilerin metabolik aktiviteleri sonucunda postbiyotik adı verilen, suda çözünebilen ekzopolisakkarid, organik asit, kısa zincirli yağ asitleri, lipoteikoik asit, hücre yüzey proteinleri, vitamin ve bakteriyosin gibi metabolitler üretilmektedir. Postbiyotikler; termal işlem, yüksek basınç, ultraviyole ışın ve sonikasyon gibi çeşitli yöntemlerle Lactobacillus ve Bifidobacterium gibi probiyotik mikroorganizmaların inaktivasyonundan elde edilmektedir. Postbiyotikler, bakteriyosin üretimi ile bağırsak mikrobiyotası ve epitel bariyer fonksiyonunun düzenlenmesi, peptidoglikan, lipoteikoik asit ve ekzopolisakkarid gibi metabolitlerin üretimi ile immün hücre yanıtının modülasyonu, antibiyofilm özelliği ile patojenlere karşı inhibitör rol üstlenmesi gibi çeşitli özelliklere sahiptir. Bu özellikleri ile antienfektif, antibakteriyel ve antioksidan etki göstererek konakçı sağlığını olumlu yönde etkilemektedir. Ayrıca postbiyotiklerin proapoptotik hücrelerin ölüm yolaklarını aktive ederek kolorektal kanser üzerinde de olumlu etkilerinin olabileceğini gösteren çalışmalar bulunmaktadır. Konakçı sağlığı üzerindeki etkilerine ek olarak ekzopolisakkarid ve bakteriyosin gibi postbiyotik çeşitleri emülgatör, stabilizatör ve kıvam artırıcı özellikleri ile besin endüstrisinde sıkça kullanılmaktadır. Tüm bu özellikleri ile postbiyotikler sağlık üzerine etkileri açısından oldukça önemlidir. Bu derleme, postbiyotikler ve sağlık üzerine etkilerini incelemek amacıyla yazılmıştır.

Anahtar Kelimeler: Postbiyotik; probiyotik; mikrobiyota; sağlık
ABSTRACT
 Intestinal microbiota consists of various microorganisms found in digestive system, skin, urogenital system and respiratory system. Synbiotics consisting of probiotics, prebiotics and the combination of these two components play an important role in maintaining microbiota homeostasis. The concept of postbiotics is a new concept that has been developing in recent years compared to probiotics, prebiotics and synbiotics. As a result of the metabolic activities of probiotic bacteria, metabolites such as water-soluble exopolysaccharide, organic acid, short-chain fatty acids, lipoteichoic acid, cell surface proteins, vitamins and bacteriocin are produced. Postbiotics are obtained from the inactivation of probiotic microorganisms such as Lactobacillus and Bifidobacterium by various methods such as thermal treatment, high pressure, ultraviolet light and sonication. Postbiotics have various features such as bacteriocin production and regulation of intestinal microbiota and epithelial barrier function, modulation of immune cell response with the production of metabolites such as peptidoglycan, lipoteichoic acid and exopolysaccharide, their antibiofilm feature and inhibitory role against pathogens. With these properties, it affects the host health positively by showing antiinfective, antibacterial and antioxidant effects. In addition, there are studies showing that postbiotics may have positive effects on colorectal cancer by activating the death pathways of proapoptotic cells. In addition to their effects on host health, postbiotic varieties such as exopolysaccharide and bacteriocin are frequently used in the food industry with their emulsifier, stabilizer and thickener properties. With all these features, postbiotics are important in terms of their effects on health. This review was written to examine postbiotics and their effects on health.

Keywords: Postbiotic; probiotic; microbiota; health
REFERENCES:
  1. Grice EA, Segre JA. The human microbiome: our second genome. Annu Rev Genomics Hum Genet. 2012;13:151-70. [Crossref]  [PubMed]  [PMC] 
  2. Malashree L, Angadi V, Yadav S, Prabha R. "Postbiotics"-One step ahead of probiotics. Int J Current Microbiol Appl Sci. 2019;8(1):2049-53. [Crossref] 
  3. Aguilar-Toalá J, Garcia-Varela R, Garcia H, Mata-Haro V, González-Córdova A, Vallejo-Cordoba B, et al. Postbiotics: An evolving term within the functional foods field. Trends Food Sci Technol. 2018;75:105-14. [Crossref] 
  4. Pelzer E, Gomez-Arango LF, Barrett HL, Nitert MD. Review: Maternal health and the placental microbiome. Placenta. 2017;54:30-37. [Crossref]  [PubMed] 
  5. Wang B, Yao M, Lv L, Ling Z, Li L. The human microbiota in health and disease. Engineering. 2017;3(1):71-82. [Crossref] 
  6. Tanaka M, Nakayama J. Development of the gut microbiota in infancy and its impact on health in later life. Allergol Int. 2017;66(4):515-22. [Crossref]  [PubMed] 
  7. Belizário JE, Faintuch J. Microbiome and Gut Dysbiosis. Exp Suppl. 2018;109:459-476. [Crossref]  [PubMed] 
  8. Drago L, Valentina C, Fabio P. Gut microbiota, dysbiosis and colon lavage. Dig Liver Dis. 2019;51(9):1209-13. [Crossref]  [PubMed] 
  9. Guarner F, Khan AG, Garisch J, Eliakim R, Gangl A, Thomson A, et al; World Gastroenterology Organization. World Gastroenterology Organisation Global Guidelines: probiotics and prebiotics October 2011. J Clin Gastroenterol. 2012;46(6):468-81. [Crossref]  [PubMed] 
  10. Tsilingiri K, Rescigno M. Postbiotics: what else? Benef Microbes. 2013;4(1):101-7. [Crossref]  [PubMed] 
  11. Matsuguchi T, Takagi A, Matsuzaki T, Nagaoka M, Ishikawa K, Yokokura T, Yoshikai Y. Lipoteichoic acids from Lactobacillus strains elicit strong tumor necrosis factor alpha-inducing activities in macrophages through Toll-like receptor 2. Clin Diagn Lab Immunol. 2003;10(2): 259- 66. [Crossref]  [PubMed]  [PMC] 
  12. Klemashevich C, Wu C, Howsmon D, Alaniz RC, Lee K, Jayaraman A. Rational identification of diet-derived postbiotics for improving intestinal microbiota function. Curr Opin Biotechnol. 2014;26:85-90. [Crossref]  [PubMed] 
  13. Rautiola E. Short chain fatty acid production by probiotic organisms in the gastrointestinal tract. Senior Honors Theses. 2013:328. [Link] 
  14. Kannampalli P, Shaker R, Sengupta JN. Colonic butyrate- algesic or analgesic? Neurogastroenterol Motil. 2011;23(11):975-9. [Crossref]  [PubMed]  [PMC] 
  15. Gill PA, van Zelm MC, Muir JG, Gibson PR. Review article: short chain fatty acids as potential therapeutic agents in human gastrointestinal and inflammatory disorders. Aliment Pharmacol Ther. 2018;48(1):15-34. [Crossref]  [PubMed] 
  16. den Besten G, Lange K, Havinga R, van Dijk TH, Gerding A, van Eunen K, et al. Gut-derived short-chain fatty acids are vividly assimilated into host carbohydrates and lipids. Am J Physiol Gastrointest Liver Physiol. 2013; 305(12):G900-10. [Crossref]  [PubMed] 
  17. LeBlanc JG, Chain F, Martín R, Bermúdez-Humarán LG, Courau S, Langella P. Beneficial effects on host energy metabolism of short-chain fatty acids and vitamins produced by commensal and probiotic bacteria. Microb Cell Fact. 2017;16(1):79. [Crossref]  [PubMed]  [PMC] 
  18. Macfarlane GT, Macfarlane S. Bacteria, colonic fermentation, and gastrointestinal health. J AOAC Int. 2012;95(1):50-60. [Crossref]  [PubMed] 
  19. Sun Y, O'Riordan MX. Regulation of bacterial pathogenesis by intestinal short-chain Fatty acids. Adv Appl Microbiol. 2013;85:93-118. [Crossref]  [PubMed]  [PMC] 
  20. Wang HB, Wang PY, Wang X, Wan YL, Liu YC. Butyrate enhances intestinal epithelial barrier function via up-regulation of tight junction protein Claudin-1 transcription. Dig Dis Sci. 2012;57(12):3126-35. [Crossref]  [PubMed] 
  21. van der Beek CM, Dejong CHC, Troost FJ, Masclee AAM, Lenaerts K. Role of short-chain fatty acids in colonic inflammation, carcinogenesis, and mucosal protection and healing. Nutr Rev. 2017;75(4):286-305. [Crossref]  [PubMed] 
  22. Feng W, Ao H, Peng C. Gut microbiota, short-chain fatty acids, and herbal medicines. Front Pharmacol. 2018;9:1354. [Crossref]  [PubMed]  [PMC] 
  23. Laws A, Gu Y, Marshall V. Biosynthesis, characterisation, and design of bacterial exopolysaccharides from lactic acid bacteria. Biotechnol Adv. 2001;19(8):597-625. [Crossref]  [PubMed] 
  24. Wegh CAM, Geerlings SY, Knol J, Roeselers G, Belzer C. Postbiotics and their potential applications in early life nutrition and beyond. Int J Mol Sci. 2019;20(19):4673. [Crossref]  [PubMed]  [PMC] 
  25. Nwodo UU, Green E, Okoh AI. Bacterial exopolysaccharides: functionality and prospects. Int J Mol Sci. 2012;13(11):14002-15. [Crossref]  [PubMed]  [PMC] 
  26. Salazar N, Gueimonde M, de Los Reyes-Gavilán CG, Ruas-Madiedo P. Exopolysaccharides Produced by Lactic Acid Bacteria and Bifidobacteria as Fermentable Substrates by the Intestinal Microbiota. Crit Rev Food Sci Nutr. 2016;56(9):1440-53. [Crossref]  [PubMed] 
  27. Brown S, Santa Maria JP Jr, Walker S. Wall teichoic acids of gram-positive bacteria. Annu Rev Microbiol. 2013;67:313-36. [Crossref]  [PubMed]  [PMC] 
  28. Lebeer S, Claes IJ, Vanderleyden J. Anti-inflammatory potential of probiotics: lipoteichoic acid makes a difference. Trends Microbiol. 2012;20(1):5-10. [Crossref]  [PubMed] 
  29. Yi ZJ, Fu YR, Li M, Gao KS, Zhang XG. Effect of LTA isolated from bifidobacteria on D-galactose-induced aging. Exp Gerontol. 2009; 44(12):760-5. [Crossref]  [PubMed] 
  30. Kang SS, Sim JR, Yun CH, Han SH. Lipoteichoic acids as a major virulence factor causing inflammatory responses via Toll-like receptor 2. Arch Pharm Res. 2016;39(11): 1519-29. [Crossref]  [PubMed] 
  31. Chikindas ML, Weeks R, Drider D, Chistyakov VA, Dicks LM. Functions and emerging applications of bacteriocins. Curr Opin Biotechnol. 2018;49:23-8. [Crossref]  [PubMed]  [PMC] 
  32. Sun-Waterhouse D, Edmonds L, Wadhwa S, Wibisono R. Producing ice cream using a substantial amount of juice from kiwifruit with green, gold or red flesh. Food Res Int. 2013;50(2):647-56. [Crossref] 
  33. Ross RP, Morgan S, Hill C. Preservation and fermentation: past, present and future. Int J Food Microbiol. 2002;79(1-2):3-16. [Crossref]  [PubMed] 
  34. FAO W. Probiotics in food. Health and nutritional properties and guidelines for evaluation. 2006. [Link] 
  35. And HC, Hoover DG. Bacteriocins and their food applications. Compr Rev Food Sci Food Saf. 2003;2(3):82-100. [Crossref]  [PubMed] 
  36. Jeevaratnam K, Jamuna M, Bawa A. Biological preservation of foods-Bacteriocins of lactic acid bacteria. Indian J Biotechnol. 2005;4(4): 446-54. [Link] 
  37. Sharma M, Shukla G. Metabiotics: One Step ahead of Probiotics; an Insight into Mechanisms Involved in Anticancerous Effect in Colorectal Cancer. Front Microbiol. 2016;7:1940. [Crossref]  [PubMed]  [PMC] 
  38. de Almada CN, Almada CN, Martinez RC, Sant'Ana AS. Paraprobiotics: evidences on their ability to modify biological responses, inactivation methods and perspectives on their application in foods. Trends Food Sci Technol. 2016;58:96-114. [Crossref] 
  39. Taverniti V, Guglielmetti S. The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept). Genes Nutr. 2011;6(3):261-74. [Crossref]  [PubMed]  [PMC] 
  40. Mosca F, Gianni ML, Rescigno M. Can postbiotics represent a new strategy for NEC? Adv Exp Med Biol. 2019;1125:37-45. [Crossref]  [PubMed] 
  41. Cicenia A, Scirocco A, Carabotti M, Pallotta L, Marignani M, Severi C. Postbiotic activities of lactobacilli-derived factors. J Clin Gastroenterol. 2014;48 Suppl 1:S18-22. [Crossref]  [PubMed] 
  42. Schaefer L, Auchtung TA, Hermans KE, Whitehead D, Borhan B, Britton RA. The antimicrobial compound reuterin (3-hydroxypropionaldehyde) induces oxidative stress via interaction with thiol groups. Microbiology (Reading). 2010;156(Pt 6):1589-99. [Crossref]  [PubMed]  [PMC] 
  43. Bermudez-Brito M, Plaza-Díaz J, Mu-oz-Quezada S, Gómez-Llorente C, Gil A. Probiotic mechanisms of action. Ann Nutr Metab. 2012;61(2):160-74. [Crossref]  [PubMed] 
  44. Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol. 2009;9(11):799-809. [Crossref]  [PubMed] 
  45. König J, Wells J, Cani PD, García-Ródenas CL, MacDonald T, Mercenier A, et al. Human intestinal barrier function in health and disease. Clin Transl Gastroenterol. 2016;7(10): e196. [Crossref]  [PubMed]  [PMC] 
  46. Gao J, Li Y, Wan Y, Hu T, Liu L, Yang S, et al. A Novel Postbiotic From Lactobacillus rhamnosus GG With a Beneficial Effect on Intestinal Barrier Function. Front Microbiol. 2019; 10:477. [Crossref]  [PubMed]  [PMC] 
  47. Quévrain E, Maubert MA, Michon C, Chain F, Marquant R, Tailhades J, et al. Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease. Gut. 2016;65(3): 415-25. [Crossref]  [PubMed]  [PMC] 
  48. Lebeer S, Bron PA, Marco ML, Van Pijkeren JP, O'Connell Motherway M, Hill C, et al. Identification of probiotic effector molecules: present state and future perspectives. Curr Opin Biotechnol. 2018;49:217-23. [Crossref]  [PubMed] 
  49. Segers ME, Lebeer S. Towards a better understanding of Lactobacillus rhamnosus GG--host interactions. Microb Cell Fact. 2014;13 Suppl 1(Suppl 1):S7. [Crossref]  [PubMed]  [PMC] 
  50. Karczewski J, Troost FJ, Konings I, Dekker J, Kleerebezem M, Brummer RJ, et al. Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. Am J Physiol Gastrointest Liver Physiol. 2010; 298(6):G851-9. [Crossref]  [PubMed] 
  51. Malagón-Rojas JN, Mantziari A, Salminen S, Szajewska H. Postbiotics for preventing and treating common ınfectious diseases in children: A systematic review. Nutrients. 2020; 12(2):389. [Crossref]  [PubMed]  [PMC] 
  52. Kim KW, Kang SS, Woo SJ, Park OJ, Ahn KB, Song KD, et al. Lipoteichoic acid of probiotic lactobacillus plantarum attenuates poly I:C-Induced IL-8 Production in porcine ıntestinal epithelial cells. Front Microbiol. 2017;8:1827. [Crossref]  [PubMed]  [PMC] 
  53. Ou CC, Lin SL, Tsai JJ, Lin MY. Heat-killed lactic acid bacteria enhance immunomodulatory potential by skewing the immune response toward Th1 polarization. J Food Sci. 2011;76(5): M260-7. [Crossref]  [PubMed] 
  54. Tsilingiri K, Barbosa T, Penna G, Caprioli F, Sonzogni A, Viale G, et al. Probiotic and postbiotic activity in health and disease: comparison on a novel polarised ex-vivo organ culture model. Gut. 2012;61(7):1007-15. [Crossref]  [PubMed] 
  55. Iraporda C, Errea A, Romanin DE, Cayet D, Pereyra E, Pignataro O, et al. Lactate and short chain fatty acids produced by microbial fermentation downregulate proinflammatory responses in intestinal epithelial cells and myeloid cells. Immunobiology. 2015;220(10): 1161-9. [Crossref]  [PubMed] 
  56. Chang PV, Hao L, Offermanns S, Medzhitov R. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci U S A. 2014;111(6):2247-52. [Crossref]  [PubMed]  [PMC] 
  57. Li S, Zhao Y, Zhang L, Zhang X, Huang L, Li D, et al. Antioxidant activity of Lactobacillus plantarum strains isolated from traditional Chinese fermented foods. Food Chem. 2012; 135(3):1914-9. [Crossref]  [PubMed] 
  58. Xu R, Shang N, Li P. In vitro and in vivo antioxidant activity of exopolysaccharide fractions from Bifidobacterium animalis RH. Anaerobe. 2011;17(5):226-31. [Crossref]  [PubMed] 
  59. Sharma S, Singh RL, Kakkar P. Modulation of Bax/Bcl-2 and caspases by probiotics during acetaminophen induced apoptosis in primary hepatocytes. Food Chem Toxicol. 2011;49(4): 770-9. [Crossref]  [PubMed] 
  60. Braithwaite D, Demb J, Henderson L. American Cancer Society: Cancer Facts and Figures 2016. Atlanta, GA: American Cancer Society. [Link] 
  61. Verma A, Shukla G. Modulation of apoptosis and immune response by symbiotic in experimental colorectal cancer. Int J Pharm Bio Sci. 2015;6(3):529-43. [Link] 
  62. Tiptiri-Kourpeti A, Spyridopoulou K, Santarmaki V, Aindelis G, Tompoulidou E, Lamprianidou EE, et al. Lactobacillus casei Exerts Anti-Proliferative Effects Accompanied by Apoptotic Cell Death and Up-Regulation of TRAIL in Colon Carcinoma Cells. PLoS One. 2016;11(2):e0147960. [Crossref]  [PubMed]  [PMC] 
  63. Escamilla J, Lane MA, Maitin V. Cell-free supernatants from probiotic Lactobacillus casei and Lactobacillus rhamnosus GG decrease colon cancer cell invasion in vitro. Nutr Cancer. 2012;64(6):871-8. [Crossref]  [PubMed] 
  64. Lupton JR. Is fiber protective against colon cancer? Where the research is leading us. Nutrition. 2000;16(7-8):558-61. [Crossref]  [PubMed] 
  65. Hijova E, Chmelarova A. Short chain fatty acids and colonic health. Bratisl Lek Listy. 2007;108(8):354-8. [PubMed] 
  66. Choe D, Foo H, Loh T, Hair-Bejo M, Awis Q. Inhibitory property of metabolite combinations produced from lactobacillus plantarum strains. Pertanika J Trop Agric Sci. 2013;36(1):79-88. [Link] 
  67. Wang K, Li W, Rui X, Chen X, Jiang M, Dong M. Characterization of a novel exopolysaccharide with antitumor activity from Lactobacillus plantarum 70810. Int J Biol Macromol. 2014;63:133-9. [Crossref]  [PubMed] 
  68. Chuah LO, Foo HL, Loh TC, Mohammed Alitheen NB, Yeap SK, Abdul Mutalib NE, et al. Postbiotic metabolites produced by Lactobacillus plantarum strains exert selective cytotoxicity effects on cancer cells. BMC Complement Altern Med. 2019;19(1):114. [Crossref]  [PubMed]  [PMC] 
  69. Han X, Yang Z, Jing X, Yu P, Zhang Y, Yi H, et al. Improvement of the Texture of Yogurt by Use of Exopolysaccharide Producing Lactic Acid Bacteria. Biomed Res Int. 2016;2016: 7945675. [Crossref]  [PubMed]  [PMC] 
  70. Lluis-Arroyo D, Flores-Nájera A, Cruz-Guerrero A, Gallardo-Escamilla F, Lobato-Calleros C, Jiménez-Guzmán J, et al. Effect of an exopolysaccharide-producing strain of Streptococcus thermophilus on the yield and texture of Mexican Manchego-type cheese. Int J Food Prop. 2014;17(8):1680-93. [Crossref] 
  71. Lynch KM, Zannini E, Coffey A, Arendt EK. Lactic acid bacteria exopolysaccharides in foods and beverages: isolation, properties, characterization, and health benefits. Annu Rev Food Sci Technol. 2018;9:155-76. [Crossref]  [PubMed] 
  72. Rühmkorf C, Rübsam H, Becker T, Bork C, Voiges K, Mischnick P, et al. Effect of structurally different microbial homoexopolysaccharides on the quality of gluten-free bread. Eur Food Res Technol. 2012;235(1):139-46. [Crossref] 
  73. Martínez-Viedma P, Abriouel H, Omar NB, Valdivia E, López RL, Gálvez A. Inactivation of exopolysaccharide and 3-hydroxypropional dehyde-producing lactic acid bacteria in apple juice and apple cider by enterocin AS-48. Food Chem Toxicol. 2008;46(3):1143-51. [Crossref]  [PubMed] 
  74. Fraunhofer ME, Jakob F, Vogel RF. Influence of different sugars and initial pH on β-Glucan Formation by Lactobacillus brevis TMW 1.2112. Curr Microbiol. 2018;75(7):794-802. [Crossref]  [PubMed] 

.: Up To Date

.: Process List

Login

 Forgot your password?

 New Registration  

Contact

Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş.

.: Address

Turkocagi Caddesi No:30 06520 Balgat / ANKARA
Phone: +90 312 286 56 56
Fax: +90 312 220 04 70
E-mail: info@turkiyeklinikleri.com

.: Manuscript Editing Department

Phone: +90 312 286 56 56/ 2
E-mail: yaziisleri@turkiyeklinikleri.com

.: English Language Redaction

Phone: +90 312 286 56 56/ 145
E-mail: tkyayindestek@turkiyeklinikleri.com

.: Marketing Sales-Project Department

Phone: +90 312 286 56 56/ 142
E-mail: reklam@turkiyeklinikleri.com

.: Subscription and Public Relations Department

Phone: +90 312 286 56 56/ 118
E-mail: abone@turkiyeklinikleri.com

.: Customer Services

Phone: +90 312 286 56 56/ 118
E-mail: satisdestek@turkiyeklinikleri.com

1. TERMS OF USE

1.1. To use the web pages with http://www.turkiyeklinikleri.com domain name or the websites reached through the sub domain names attached to the domain name (They will be collectively referred as "SITE"), please read the conditions below. If you do not accept these terms, please cease to use the "SITE." "SITE" owner reserves the right to change the information on the website, forms, contents, the "SITE," "SITE" terms of use anytime they want.

1.2. The owner of the "SITE" is Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. (From now on it is going to be referred as "Turkiye Klinikleri", shortly) and it resides at Turkocagi cad. No:30, 06520 Balgat Ankara. The services in the "SITE" are provided by "Turkiye Klinikleri."

1.3. Anyone accessing the "SITE" with or without a fee whether they are a natural person or a legal identity is considered to agree these terms of use. In this contract hereby, "Turkiye Klinikleri" may change the stated terms anytime. These changes will be published in the "SITE" periodically and they will be valid when they are published. Any natural person or legal identity benefiting from and reaching to the "SITE" are considered to be agreed to any change on hereby contract terms done by "Turkiye Klinikleri."

1.4. The "Terms of Use" hereby is published in the website with the last change on March 30th 2014 and the "SITE" is activated by enabling the access to everyone. The "Terms of Use" hereby is also a part of the any "USER Contract" was and/or will be done with the users using "Turkiye Klinikleri" services with or without a fee an inseparable.

2. DEFINITIONS

2.1. "SITE": A website offering different kind of services and context with a certain frame determined by "Turkiye Klinikleri" and it is accessible on-line on http://www.turkiyeklinikleri.com domain name and/or subdomains connected to the domain name.

2.2. USER: A natural person or a legal identity accessing to the "SITE" through online settings.

2.3. LINK: A link enabling to access to another website through the "SITE", the files, the context or through another website to the "SITE", the files and the context.

2.4. CONTEXT: Any visual, literary and auditory images published in the "Turkiye Klinikleri", "SITE" and/or any website or any accessible information, file, picture, number/figures, price, etc.

2.5. "USER CONTRACT": An electronically signed contract between a natural or a legal identity benefiting from special services "Turkiye Klinikleri" will provide and "Turkiye Klinikleri".

3. SCOPE OF THE SERVICES

3.1. "Turkiye Klinikleri" is completely free to determine the scope and quality of the services via the "SITE".

3.2. To benefit the services of "Turkiye Klinikleri" "SITE", the "USER" must deliver the features that will be specified by "Turkiye Klinikleri". "Turkiye Klinikleri" may change this necessity any time single-sided.

3.3. Not for a limited number, the services "Turkiye Klinikleri" will provide through the "SITE" for a certain price or for free are;

- Providing scientific articles, books and informative publications for health industry.

- Providing structural, statistical and editorial support to article preparation stage for scientific journals.

4. GENERAL PROVISIONS

4.1. "Turkiye Klinikleri" is completely free to determine which of the services and contents provided in the "SITE" will be charged.

4.2. People benefiting from the services provided by "Turkiye Klinikleri" and using the website can use the "SITE" only according to the law and only for personal reasons. Users have the criminal and civil liability for every process and action they take in the "SITE". Every USER agrees, declares and undertakes that they will not proceed by any function or action infringement of rights of "Turkiye Klinikleri"s and/or other third parties', they are the exclusive right holder on usage, processing, storage, made public and revealing any written, visual or auditory information reported to Turkiye Klinikleri" and/or "SITE" to the third parties. "USER" agrees and undertakes that s/he will not duplicate, copy, distribute, process, the pictures, text, visual and auditory images, video clips, files, databases, catalogs and lists within the "SITE", s/he will not be using these actions or with other ways to compete with "Turkiye Klinikleri", directly or indirectly.

4.3. The services provided and the context published within the "SITE" by third parties is not under the responsibility of "Turkiye Klinikleri", institutions collaborated with "Turkiye Klinikleri", "Turkiye Klinikleri" employee and directors, "Turkiye Klinikleri" authorized salespeople. Commitment to accuracy and legality of the published information, context, visual and auditory images provided by any third party are under the full responsibility of the third party. "Turkiye Klinikleri" does not promise and guarantee the safety, accuracy and legality of the services and context provided by a third party.

4.4. "USER"s cannot act against "Turkiye Klinikleri", other "USER"s and third parties by using the "SITE". "Turkiye Klinikleri" has no direct and/or indirect responsibility for any damage a third party suffered or will suffer regarding "USER"s actions on the "SITE" against the rules of the hereby "Terms of Use" and the law.

4.5. "USER"s accept and undertake that the information and context they provided to the "SITE" are accurate and legal. "Turkiye Klinikleri" is not liable and responsible for promising and guaranteeing the verification of the information and context transmitted to "Turkiye Klinikleri" by the "USER"s, or uploaded, changed and provided through the "SITE" by them and whether these information are safe, accurate and legal.

4.6. "USER"s agree and undertake that they will not perform any action leading to unfair competition, weakening the personal and commercial credit of "Turkiye Klinikleri" and a third party,  encroaching and attacking on personal rights within the "SITE" in accordance with the Turkish Commercial Code Law.

4.7. "Turkiye Klinikleri" reserves the right to change the services and the context within the "SITE"  anytime. "Turkiye Klinikleri" may use this right without any notification and timelessly. "USER"s have to make the changes and/or corrections "Turkiye Klinikleri" required immediately. Any changes and/or corrections that are required by "Turkiye Klinikleri", may be made by "Turkiye Klinikleri" when needed. Any harm, criminal and civil liability resulted or will result from changes and/or corrections required by "Turkiye Klinikleri" and were not made on time by the "USER"s belongs completely to the users.

4.8. "Turkiye Klinikleri" may give links through the "SITE" to other websites and/or "CONTEXT"s and/or folders that are outside of their control and owned and run by third parties. These links are provided for ease of reference only and do not hold qualification for support the respective web SITE or the admin or declaration or guarantee for the information inside. "Turkiye Klinikleri" does not hold any responsibility over the web-sites connected through the links on the "SITE", folders and context, the services or products on the websites provided through these links or their context.

4.9. "Turkiye Klinikleri" may use the information provided to them by the "USERS" through the "SITE" in line with the terms of the "PRIVACY POLICY" and "USER CONTRACT". It may process the information or classify and save them on a database. "Turkiye Klinikleri" may also use the USER's or visitor's identity, address, e-mail address, phone number, IP number, which sections of the "SITE" they visited, domain type, browser type, date and time information to provide statistical evaluation and customized services.

5. PROPRIETARY RIGHTS

5.1. The information accessed through this "SITE" or provided by the users legally and all the elements (including but not limited to design, text, image, html code and other codes) of the "SITE" (all of them will be called as studies tied to "Turkiye Klinikleri"s copyrights) belongs to "Turkiye Klinikleri". Users do not have the right to resell, process, share, distribute, display or give someone permission to access or to use the "Turkiye Klinikleri" services, "Turkiye Klinikleri" information and the products under copyright protection by "Turkiye Klinikleri". Within hereby "Terms of Use" unless explicitly permitted by "Turkiye Klinikleri" nobody can reproduce, process, distribute or produce or prepare any study from those under "Turkiye Klinikleri" copyright protection.

5.2. Within hereby "Terms of Use", "Turkiye Klinikleri" reserves the rights for "Turkiye Klinikleri" services, "Turkiye Klinikleri" information, the products associated with "Turkiye Klinikleri" copyrights, "Turkiye Klinikleri" trademarks, "Turkiye Klinikleri" trade looks or its all rights for other entity and information it has through this website unless it is explicitly authorized by "Turkiye Klinikleri".

6. CHANGES IN THE TERMS OF USE

"Turkiye Klinikleri" in its sole discretion may change the hereby "Terms of Use" anytime announcing within the "SITE". The changed terms of the hereby "Terms of Use" will become valid when they are announced. Hereby "Terms of Use" cannot be changed by unilateral declarations of users.

7. FORCE MAJEURE

"Turkiye Klinikleri" is not responsible for executing late or never of this hereby "Terms of Use", privacy policy and "USER Contract" in any situation legally taken into account as force majeure. Being late or failure of performance or non-defaulting of this and similar cases like this will not be the case from the viewpoint of "Turkiye Klinikleri", and "Turkiye Klinikleri" will not have any damage liability for these situations. "Force majeure" term will be regarded as outside of the concerned party's reasonable control and any situation that "Turkiye Klinikleri" cannot prevent even though it shows due diligence. Also, force majeure situations include but not limited to natural disasters, rebellion, war, strike, communication problems, infrastructure and internet failure, power cut and bad weather conditions.

8. LAW AND AUTHORISATION TO FOLLOW

Turkish Law will be applied in practicing, interpreting the hereby "Terms of Use" and managing the emerging legal relationships within this "Terms of Use" in case of finding element of foreignness, except for the rules of Turkish conflict of laws. Ankara Courts and Enforcement Offices are entitled in any controversy happened or may happen due to hereby contract.

9. CLOSING AND AGREEMENT

Hereby "Terms of Use" come into force when announced in the "SITE" by "Turkiye Klinikleri". The users are regarded to agree to hereby contract terms by using the "SITE". "Turkiye Klinikleri" may change the contract terms and the changes will be come into force by specifying the version number and the date of change on time it is published in the "SITE".

 

30.03.2014

Privacy Policy

We recommend you to read the terms of use below before you visit our website. In case you agree these terms, following our rules will be to your favor. Please read our Terms of Use thoroughly.

www.turkiyeklinikleri.com website belongs to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. and is designed in order to inform physicians in the field of health

www.turkiyeklinikleri.com cannot reach to user’s identity, address, service providers or other information. The users may send this information to the website through forms if they would like to. However, www.turkiyeklinikleri.com may collect your hardware and software information. The information consists of your IP address, browser type, operating system, domain name, access time, and related websites. www.turkiyeklinikleri.com cannot sell the provided user information (your name, e-mail address, home and work address, phone number) to the third parties, publish it publicly, or keep it in the website. Gathered information has a directing feature to be a source for the website’s visitor profile, reporting and promotion of the services.

www.turkiyeklinikleri.com uses the taken information:

-To enhance, improve and maintain the quality of the website

-To generate visitor’s profile and statistical data

-To determine the tendency of the visitors on using our website

-To send print publications/correspondences

-To send press releases or notifications through e-mail

-To generate a list for an event or competition

By using www.turkiyeklinikleri.com you are considered to agree that;

-Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. cannot be hold responsible for any user’s illegal and immoral behavior,

-Terms of use may change from time to time,

-It is not responsible for other websites’ contents it cannot control or the harms they may cause although it uses the connection they provided.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. may block the website to users in the following events:

-Information with wrong, incomplete, deceiving or immoral expressions is recorded to the website,

-Proclamation, advertisement, announcement, libelous expressions are used against natural person or legal identity,

-During various attacks to the website,

-Disruption of the website because of a virus.

Written, visual and audible materials of the website, including the code and the software are under protection by legal legislation.

Without the written consent of Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. the information on the website cannot be downloaded, changed, reproduced, copied, republished, posted or distributed.

All rights of the software and the design of the website belong to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. will be pleased to hear your comments about our terms of use. Please share the subjects you think may enrich our website or if there is any problem regarding our website.

info@turkiyeklinikleri.com